GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (FRA:7UX) » Definitions » PS Ratio

Spago Nanomedical AB (FRA:7UX) PS Ratio : (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Spago Nanomedical AB PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Spago Nanomedical AB's share price is €0.0208. Spago Nanomedical AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00. Hence, Spago Nanomedical AB's PS Ratio for today is .

The historical rank and industry rank for Spago Nanomedical AB's PS Ratio or its related term are showing as below:

FRA:7UX' s PS Ratio Range Over the Past 10 Years
Min: 31.67   Med: 1364.11   Max: 14185.18
Current: 53.8

During the past 12 years, Spago Nanomedical AB's highest PS Ratio was 14185.18. The lowest was 31.67. And the median was 1364.11.

FRA:7UX's PS Ratio is ranked worse than
80.16% of 998 companies
in the Biotechnology industry
Industry Median: 9.14 vs FRA:7UX: 53.80

Spago Nanomedical AB's Revenue per Sharefor the three months ended in Mar. 2024 was €0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00.

During the past 12 months, the average Revenue per Share Growth Rate of Spago Nanomedical AB was -66.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 152.00% per year.

During the past 12 years, Spago Nanomedical AB's highest 3-Year average Revenue per Share Growth Rate was 152.00% per year. The lowest was -86.40% per year. And the median was -35.65% per year.

Back to Basics: PS Ratio


Spago Nanomedical AB PS Ratio Historical Data

The historical data trend for Spago Nanomedical AB's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB PS Ratio Chart

Spago Nanomedical AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 668.60 282.66 37.61

Spago Nanomedical AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.61 55.26 77.13 53.96 58.00

Competitive Comparison of Spago Nanomedical AB's PS Ratio

For the Biotechnology subindustry, Spago Nanomedical AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's PS Ratio distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's PS Ratio falls into.



Spago Nanomedical AB PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Spago Nanomedical AB's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0208/0
=

Spago Nanomedical AB's Share Price of today is €0.0208.
Spago Nanomedical AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Spago Nanomedical AB  (FRA:7UX) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Spago Nanomedical AB PS Ratio Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB (FRA:7UX) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (FRA:7UX) Headlines

No Headlines